What the panel ordered
Findings and Award of February 17, 2021 affirmed except paragraphs (A) and (C) of the Award rescinded; Findings 5, 6, 7 and 9 amended to defer issues of chronic lung disease, self-procured medical treatment, temporary disability beyond Finding 4, and attorney’s fees; matter returned to trial level for further proceedings and new decision by the WCJp. 5
Defendant petitioned for reconsideration of WCJ’s Findings and Award of February 17, 2021; Appeals Board granted reconsideration, rescinded portions of the award, and returned the matter for further development of the medical record
What was disputed, and how it came out
Each issue the panel decided, with the reasoning it gave. An outcome is what this panel did on this record — not a rule, and not a prediction.
No substantial medical evidence that applicant has the medical diagnosis of chronic lung disease; requires supplemental PQME opinion
From the decision · page 55. The issue of whether applicant has “chronic lung disease” within the meaning of Lab. Code, § 4656(c)(3)(I) is deferred pending further proceedings and determination by the WCJ, jurisdiction reserved.